Lv51
890 积分 2025-04-30 加入
A multi-platform characterization of aggregation in morpholino oligonucleotide drug products: From soluble aggregates to subvisible particles
2小时前
已完结
A multi-platform characterization of aggregation in morpholino oligonucleotide drug products: From soluble aggregates to subvisible particles
2小时前
求助中
Toward the Establishment of a Harmonized Physicochemical Profiling Platform for Therapeutic Oligonucleotides: A Case Study for Aptamers Where the Higher-Order Structure Influences Physical Properties
2个月前
已完结
Assay, Purity, and Impurity Profile of Phosphorothioate Oligonucleotide Therapeutics by Ion Pair-HPLC-MS
3个月前
已完结
Impurity profiling of siRNA by two-dimensional liquid chromatography-mass spectrometry with quinine carbamate anion-exchanger and ion-pair reversed-phase chromatography
4个月前
已完结
Chemical cleavage coupled with LCMS to report on the true diastereomeric distributions of phosphorothioate linkages in gapmer ASO
9个月前
已完结
Chemical cleavage coupled with LCMS to report on the true diastereomeric distributions of phosphorothioate linkages in gapmer ASO
9个月前
已完结
Automated determination of early eluting oligonucleotide impurities using ion-pair reversed-phase liquid chromatography high resolution-mass spectrometry
9个月前
已完结
Chapter 13: Impact of Impurities on the Quality and Safety of Oligonucleotides as Drug Substances
9个月前
已完结